Abbott Vascular Prospects Aid 23% Stock Gain In 2006 – Index Up 5.7%
This article was originally published in The Gray Sheet
Executive Summary
Abbott's and Johnson & Johnson's guidance to the device industry in 2006 was that diversification is key and some acquisitions are too good to pass up